Apimeds, Inc.: Clinical Trials

3 trials sponsored by Apimeds, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 unknown. 2 Phase 3, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 32Completed 1, Unknown 1
Phase 21Completed 1

Follow Apimeds, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Evaluate Safety and Efficacy of Apitox Add-on Therapy for Improving Disability and Quality of Life in MS Patients
Apitox - pure honeybee toxin, Placebo - Multiple Sclerosis
Phase 3UnknownApimeds, Inc.4682019-04-012018-10-18
Apitox, Honeybee Toxin for Pain and Inflammation of Osteoarthritis
Apitox, purified honeybee toxin, lyophilized in saline, histamine - Osteoarthritis of the Knee
Phase 3CompletedApimeds, Inc.3632013-12-012016-12-13
Apitox, Honeybee Venom Treatment for Osteoarthritis Pain and Inflammation
honeybee venom (Apitoxin (Korea) Apitox (USA)) - Osteoarthritis of the Knee
Phase 2CompletedApimeds, Inc.402009-10-012010-05-05

Conditions studied

Pain (3)  ·  Osteoarthritis (2)  ·  Osteoarthritis, Knee (2)  ·  Inflammation (1)  ·  Multiple Sclerosis (1)

Interventions

Bee Venoms (3)  ·  Histamine (2)  ·  Sodium Chloride (1)

Countries

United States (2)

Top investigators

Robert Brooks, PhD (2)  ·  Christopher M. H. Kim, M.D. (1)  ·  Christopher MH Kim, M.D. (1)